image
Healthcare - Biotechnology - NASDAQ - US
$ 41.1
1.61 %
$ 2.66 B
Market Cap
-17.56
P/E
KYMR - OTHER CURRENT LIABILITIES

Other Current Liabilities KYMR - Kymera Therapeutics, Inc.

image
34.4 M
LAST VALUE
32.46%
2 YEAR CAGR
71.34%
5 YEAR CAGR
0.00%
10 YEAR CAGR